N-acetylcysteine for Tobacco Use Disorder

PHASE2CompletedINTERVENTIONAL
Enrollment

114

Participants

Timeline

Start Date

August 30, 2016

Primary Completion Date

August 1, 2019

Study Completion Date

October 10, 2019

Conditions
Nicotine DependenceSmoking
Interventions
DRUG

N-acetylcysteine (NAC)

NAC or matched placebo will be given to study participants for 8 weeks.

OTHER

Placebo

Matched placebo (2 capsules taken in the morning and evening) will be taken by study participants for eight weeks. All participants will receive brief smoking cessation counseling and support.

Trial Locations (1)

29425

Medical University of South Carolina, Charleston

All Listed Sponsors
collaborator

National Institute on Drug Abuse (NIDA)

NIH

lead

Medical University of South Carolina

OTHER

NCT02737358 - N-acetylcysteine for Tobacco Use Disorder | Biotech Hunter | Biotech Hunter